Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

RAD to present at TD Cowen Annual Healthcare Conference

Monday, February 24, 2025 1 min read
Key Takeaway: Radiopharm Theranostics (RADX) is set to present at the TD Cowen Annual Healthcare Conference. This event highlights the company's ongoing commitment to engage with the investment community and share updates on its clinical programs. The presentation is expected to provide insights into RAD's advancements and future plans.
Price reaction · baseline $4.68 (2025-02-21 close) · hit pre-market · 2 other RADX headline(s) in the window, move may be shared
day 0 close · peak
-0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • RAD will present at a significant healthcare conference.
  • The company is actively engaging with investors.
  • Positive clinical updates have been shared across multiple programs.

Full Press Release Details

• Announcements
• February 24, 2025
Loading Viewer…

More Announcements & Updates

• Announcements
• December 18, 2024
• Announcements
• September 5, 2022
• Announcements
• December 9, 2022
• Announcements
• March 3, 2023

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

When will RAD present at the TD Cowen Conference?

RAD will present at the TD Cowen Annual Healthcare Conference in June 2026.

What is the focus of RAD's presentation?

The presentation will focus on RAD's clinical advancements and updates on its programs.

What recent updates has RAD shared?

RAD has provided positive clinical updates across four of its programs.

Who is part of RAD's Scientific Advisory Board?

Dr. Oliver Sartor has been appointed to Radiopharm's Scientific Advisory Board.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics TD Cowen healthcare conference clinical updates
Last updated: Feb 24, 2025